Delivery Order SPE2DB22D2007-SPE2DB25FJ4SD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,234.96 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus sensors on September 24, 2025, with completion expected by September 25, 2025. This non-competitive, firm fixed-price delivery order represents a small-value medical supply procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal healthcare vendor that supplies a comprehensive...
- The Defense Logistics Agency awarded a $10,379.49 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 sensors, effective August 18, 2025, with completion by August 19, 2025. This is a firm fixed price, non-set-aside contract performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, which carries a $999,999,999...
- The Defense Logistics Agency awarded a $4,468 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with a completion date of September 23, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the DLA's...
- The Defense Logistics Agency awarded a $2,836.28 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with an ultimate completion date of September 8, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,584.76 for Freestyle Libre 3 Plus Sensors on September 24, 2025, with completion scheduled for September 25, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery will be performed at the...
- The Defense Logistics Agency awarded a delivery order valued at $26,907.78 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on August 26, 2025, with completion targeted for August 27, 2025. This non-set-aside, firm fixed price delivery order represents a competitively awarded procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for the federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,132.06 to AmerisourceBergen Drug Corp for Freestyle Libre 3 sensors on September 25, 2025, with completion scheduled for September 26, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a $22,154.91 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 sensors, with a completion date of September 5, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical and medical supply distributor for federal healthcare systems, including military and veteran programs. The Freestyle Libre 3 sensors...
- The Defense Logistics Agency awarded a delivery order valued at $2,394.90 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on September 18, 2025, with an ultimate completion date of September 19, 2025. This non-set-aside, firm fixed price contract represents a single delivery order fulfilling immediate federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a $6,929.77 firm fixed price delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 sensors, with an ultimate completion date of May 22, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4SDDelivery Order
The Defense Logistics Agency awarded a $8,727.79 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 sensors, with a completion date of September 8, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The Freestyle Libre 3 sensors being procured represent diabetes management supplies, consistent with AmerisourceBergen's portfolio of therapeutic medical devices and medications delivered through the DLA's Pharmaceutical Prime Vendor program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.7k | 9/5/25 |